DSC ADVISORS L P
Q1 2021 Form 13-F
CHICAGO, ILLINOIS
CIK 0001299434
· CRD 158312
· SEC-registered investment adviser
Consolidated report · includes
1 manager
since Q2 2017
$161.4M Reported Value Total
DSC ADVISORS, L.P. reports 2 total accounts under management (AUM). There are 2 discretionary accounts valued at $380,873,577, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered
Discretionary Manager
Private funds (Form ADV)
6 funds
· $483.9M gross asset value
Hedge Fund: $483.9M
Source: Form ADV filed 2020-02-14
Reported value
$161.4M
Quarter over quarter
+11.1%
Holdings
75
Top-10 concentration
69.1%
Filing Structure
Reports holdings for
- DSCQG PR LLC · File #028-18129 · since Q2 2017
- DSCQG PR LLC (not a 13F filer in our records) · Q4 2016 – Q1 2017 · declared by one filing
- DACQG PR LLC (not a 13F filer in our records) · Q3 2016 – Q3 2016 · declared by one filing
- DSC Quantitative Group, LLC (not a 13F filer in our records) · Q2 2013 – Q2 2016 · declared by one filing
Key People
Form ADV owners & control persons
Andrew Gordon Bluhm
PRINCIPAL
Amy Catherine Close
CHIEF COMPLIANCE OFFICER
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q1 2021 13F record
Q1 2021 13F filing summary
| Period of report | March 31, 2021 |
|---|---|
| Filed | May 14, 2021 |
| Form | 13F-HR |
| Reported value | $161.4M |
| Positions | 75 |
| Change in reported value | +33.5% |
| New positions | 43 |
| Exited positions | 8 |
| Position turnover | 61.5% |
| Top-10 concentration | 69.1% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2024 13F
Filed Nov 14, 2024
|
19 | $11.0M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
23 | $30.0M |
|
Q1 2024 13F
Filed May 15, 2024
|
30 | $62.6M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
26 | $60.5M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
26 | $77.9M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
25 | $66.7M |
|
Q1 2023 13F
Filed May 15, 2023
|
19 | $114.5M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
15 | $43.5M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
93 | $97.0M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
109 | $100.1M |
|
Q1 2022 13F
Filed May 16, 2022
|
127 | $290.3M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
68 | $129.4M |
|
Q3 2021 13F
Filed Nov 15, 2021
|
68 | $98.5M |
|
Q2 2021 13F
Filed Aug 16, 2021
|
65 | $138.4M |
|
Q1 2021 13F
Filed May 14, 2021
|
75 | $161.4M |
|
Q4 2020 13F
Filed Feb 16, 2021
|
40 | $120.9M |
|
Q3 2020 13F
Filed Nov 16, 2020
|
39 | $149.5M |
|
Q2 2020 13F
Filed Aug 14, 2020
|
29 | $91.2M |
|
Q1 2020 13F
Filed May 15, 2020
|
28 | $102.4M |
|
Q4 2019 13F
Filed Feb 14, 2020
|
79 | $208.7M |
26 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q1 2021
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | GOOG ALPHABET INC | $21.3M | 13.2% |
| 2 | ATH ATHENE HOLDING LTD | $16.8M | 10.4% |
| 3 | QQQ P INVESCO QQQ TR | $16.0M | 9.89% |
| 4 | MS MORGAN STANLEY | $15.0M | 9.31% |
| 5 | MS C MORGAN STANLEY | $14.8M | 9.14% |
| 6 | CVS CVS HEALTH CORP | $10.0M | 6.21% |
| 7 | VYNE VYNE THERAPEUTICS INC | $7.1M | 4.4% |
| 8 | BMY BRISTOL-MYERS SQUIBB CO | $4.2M | 2.63% |
| 9 | CVS C CVS HEALTH CORP | $3.4M | 2.11% |
| 10 | COR AMERISOURCEBERGEN CORP | $3.0M | 1.83% |
| 11 | GBT GLOBAL BLOOD THERAPEUTICS IN | $2.9M | 1.77% |
| 12 | REMX C VANECK VECTORS ETF TR | $2.4M | 1.51% |
| 13 | SLV C ISHARES SILVER TR | $2.3M | 1.41% |
| 14 | GOOGL ALPHABET INC | $2.2M | 1.36% |
| 15 | EHTH EHEALTH INC | $2.2M | 1.35% |
| 16 | MSFT MICROSOFT CORP | $2.2M | 1.35% |
| 17 | META FACEBOOK INC | $1.8M | 1.1% |
| 18 | DVA DAVITA INC | $1.8M | 1.1% |
| 19 | AAPL APPLE INC | $1.7M | 1.07% |
| 20 | AMZN AMAZON COM INC | $1.5M | 0.9% |
Values as reported on the Q1 2021 Form 13F. Every position is in the holdings table below.